The genetic toxicity of the peroxisome proliferator class of rodent hepatocarcinogen

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 448, Issue 2, 2000, Pages 153-158

  Galloway, Sheila M ^a   Johnson, Timothy E ^a   Armstrong, Michael J ^a   Ashby, John ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Chromosome breakage; Cytotoxicity; Hepatocarcinogenicity; Non genotoxic carcinogens; Peroxisome proliferators

Indexed keywords

CYCLOPHOSPHAMIDE; DIMETHYL SULFOXIDE; METHYLCLOFENAPATE; MITOMYCIN C; NAFENOPIN; PEROXISOME PROLIFERATOR; PHTHALIC ACID 2 ETHYLHEXYL MONOESTER; PIRINIXIC ACID;

ANIMAL CELL; ARTICLE; CELL CULTURE; CHO CELL; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; DOSE RESPONSE; DRUG SOLUBILITY; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CARCINOGENESIS; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; RODENT;

ANIMALS; CHO CELLS; CLOFENAPATE; CRICETINAE; DIETHYLHEXYL PHTHALATE; HUMANS; MOLECULAR STRUCTURE; NAFENOPIN; PEROXISOME PROLIFERATORS; PYRIMIDINES;

RODENTIA;

EID: 0034677707     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(99)00233-X     Document Type: Article

References (13)

1. Ashby J., Brady A., Elcombe C.R., Elliott B.M., Ishmael J., Odum J., Tugwood J.D., Kettle S., Purchase I.F.H.P. Mechanistically-based human hazard assessment of peroxisome proliferator induced hepatocarcinogenesis. Hum. Exp. Pathol. 13(Supplement 2):1994;49-117.
2. Lefevre P.A., Tinwell H., Galloway S.M., Hill R., Mackay J.M., Elcombe C.R., Foster J., Randall V., Callender R.D., Ashby J. Evaluation of the genetic toxicity of the peroxisome proliferator methyl clofenapate including assays using Muta™ Mouse and Big Blue™ transgenic mice. Hum. Exp. Pathol. 13:1994;764-775.
3. Reddy J., Azarnoff D., Svodoba D., Prasad J. Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice: absence of sex difference in response. J. Cell Biol. 61:1974;344-358.
4. Staubli W., Schweizer W., Suter J., Weibel E. The proliferative response of hepatic peroxisomes of neonatal rats to Su-13,437 (nafenopin). J. Cell Biol. 74:1977;665-689.
5. Reddy J., Rao M. Malignant tumors in rats fed nafenopin, a hepatic peroxisome proliferator. J. Natl. Cancer Inst. 59:1977;1645-1650.
6. Reddy J., Rao M., Moody D. Hepatocellular carcinoma in acatalasemic mice treated with nafenopin, a hypolipidaemic peroxisome proliferator. Cancer Res. 36:1976;1211-1217.
7. Williams G. The detection of genotoxic chemicals in the hepatocyte primary culture/DNA repair test. Inui N., Kuroki I., Yamada M.-A., Heidelberger C. Mutation, Promotion and Transformation In Vitro: Gann Monograph on Cancer Research No. 27. 1981;45-55 Japan Scientific Society Press, Tokyo.
8. 3H-thymidine and Salmonella mutagenesis assays. Cancer Res. 40:1980;36-41.
9. Reisenbichler H., Eckl P. Genotoxic effects of selected peroxisome proliferators. Mutat. Res. 286:1993;135-144.
10. Phillips P.J., James T.E.B., Gangolli S.D. Genotoxicity studies of di(2-ethylhexyl) phthalate and its metabolites in CHO cells. Mutat. Res. 102:1982;297-304.
11. Storer R.D., McKelvey T.W., Kraynak A.R., Elia M.C., Barnum J.E., Harmon L.S., Nichols W.W., DeLuca J.G. Revalidation of the in vitro alkaline elution/rat hepatocyte assay for DNA damage; improved criteria for assessment of cytotoxicity and genotoxicity and results for 81 compounds. Mutat. Res. 368:1996;59-101.
12. Hilliard C.A., Armstrong M.J., Bradt C.I., Hill R.B., Greenwood S.K., Galloway S.M. Chromosome aberrations in vitro related to cytotoxicity of non-mutagenic chemicals and metabolic poisons. Environ. Mol. Mutagen. 31:1998;316-326.
13. Müller-Tegethoff K., Kasper P., Müller L. Evaluation studies on the in vitro rat hepatocyte micronucleus assay. Mutat. Res. 335:1995;293-307.